Corbus Pharmaceuticals Holdings (CRBP) Capital Expenditures (QoQ) (2015 - 2022)
Corbus Pharmaceuticals Holdings (CRBP) Capital Expenditures (QoQ) (2015 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -75.17% |
| Dec 31, 2020 | -191.70% |
| Sep 30, 2020 | 251.17% |
| Jun 30, 2020 | -96.51% |
| Mar 31, 2020 | -64.10% |
| Dec 31, 2019 | 8.15% |
| Sep 30, 2019 | 537.10% |
| Jun 30, 2019 | 169.86% |
| Mar 31, 2019 | 175.89% |
| Dec 31, 2018 | -259.05% |
| Sep 30, 2018 | 104.66% |
| Jun 30, 2018 | -197.23% |
| Mar 31, 2018 | 118.85% |
| Dec 31, 2017 | 1,177.09% |
| Sep 30, 2017 | 8.98% |
| Jun 30, 2017 | 3.87% |
| Mar 31, 2017 | 118.00% |
| Dec 31, 2016 | -419.06% |
| Sep 30, 2016 | -6.14% |
| Jun 30, 2016 | -33.97% |